Search for: "Novartis Pharmaceuticals Corp" Results 41 - 60 of 368
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Jul 2018, 9:06 am by maxvalblog
We have talked about the FDA’s approval of tisagenlecleucel (KYMRIAH, Novartis Pharmaceuticals Corp.), a CD19-directed genetically modified autologous T-cell immunotherapy, to include treatment of patients with relapsed or refractory large B-cell lymphoma. [read post]
29 Jun 2018, 7:50 am by Jason Rantanen
  In July 2010, Momenta Pharmaceuticals, in conjunction with Novartis’s Sandoz division, received FDA approval for a biosimilar version of enoxaparin. [read post]
21 Feb 2018, 7:45 pm by Scott McKeown
Torrent Pharmaceuticals (here) The PTAB’s Institution Decision in Novartis denied grounds including a prior art reference known as “Sakai. [read post]
18 Sep 2017, 1:36 am
The first Zurich IP Retreat was held on Friday/Saturday 8/9 September 2017 on the shores of lake Zurich, organized by INGRES and ETH Zurich, in honour of Dr. [read post]
12 Apr 2017, 9:52 am by Lawrence B. Ebert
Patent No.8,324,283 (the ’283 patent), owned by Novartis AG andMistubishi Tanabe Pharma Corp. [read post]
23 Aug 2016, 10:34 am by Lawrence B. Ebert
” Appellee Br.at 7 n.3 (citing Novartis Pharmaceuticals Corp. v. [read post]
3 Mar 2016, 5:19 am
Novartis Pharmaceuticals Corp., 247 P.3d 244, 257 (Mont. 2010); Downing v. [read post]
22 Oct 2015, 8:42 am
  Sorrell, of course, held that pharmaceutical promotion was First Amendment protected speech, as we discussed here. [read post]